Dr. Reddys Laboratories Ltd.

Dr. Reddy’s Laboratories has informed that the United States Food & Drug Administration (USFDA) completed a routine cGMP inspection at its formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad. The inspection was conducted from October 19, 2023 to October 27, 2023. The company has been issued a Form 483 with ten observations, which will address within the stipulated timeline.

The above information is a part of company’s filings submitted to BSE.